CONFERENCE COVERAGE
Digestive Disease Week
Annual Meeting
2022 COVERAGE
- Rifaximin Effective for Treating Multiple Symptoms in IBS-D
- DASH Diet May Be Protective of Incident NAFLD Risk
- Early ERCP Linked to Shorter Hospitalization in ABP
- EoE Severity Index Linked to Clinical Features, Treatment Response
- Concomitant PPI and Advanced Therapy Linked to Worse Outcomes in IBD
- Risk for Advanced Colorectal Neoplasia in Young Adults Tied to Age, Tobacco, and More
- Mucosa, C-Reactive Proteins Predict Ulcerative Colitis Relapse
- Oral Microbiome Therapy Sustains Clinical Cure for Recurrent CDI
- Fecal Hemoglobin Concentration May Predict Advanced Neoplasia, Colorectal Cancer
- Liver Test Abnormalities in Patients With COVID-19 Not Associated With Cytokine Storm
- Combined Food Allergies, Eosinophilic Esophagitis May Weaken PPI Response
- Postoperative Recurrence of Crohn Disease Linked to Sex and Ethnicity
Latest Tweets
Follow
@DDWMeeting
Conference Coverage from
